While the entire world fights a pandemic that can be defeated only by Science and the latest biotech approaches, Pharma's Almanac asked our CEO, Patricio Massera, the following question for their Jan. 2022 Experts Roundtable:
Recent Posts by Marketing Team:
Cancer and Rare Disease: What Progress Can Be Expected in these Fields in 2022 and beyond?
Marketing Team Published on 1/14/22 9:00 AM Thought Leadership, Other Media
Learn More
Personalized Medicine in 2022: Allogeneic Treatments Can be the Effective “Brick in the Wall” for Cell and Gene Therapy Treatments
Marketing Team Published on 1/13/22 9:00 AM Thought Leadership, Other Media
Personalized medicine offers the opportunity to create treatments for patients based on their specific needs. However, one of the major issues with
personalized medicine is the cost of goods (COGs), and the healthcare industry is continuously looking for new strategies to address this challenge and help make customized healthcare more readily available to patients that need it.
Follow Us
